Literature DB >> 22117965

The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.

L Gao1, H Y Cheng, L Dong, X Ye, Y N Liu, X H Chang, Y X Cheng, J Chen, R Q Ma, H Cui.   

Abstract

As a promising biomarker, human epididymis protein 4 (HE4) has been widely used for the early detection and differential diagnosis of ovarian cancer. This study evaluated the function of HE4 in the carcinogenesis and progression of ovarian cancer. An enzyme immunometric assay, used to detect HE4 in the serum of ovarian cancer patients, showed that the protein could discriminate between malignant and benign ovarian tumours with high specificity. An exogenous HE4 gene was transfected into ovarian cancer cell lines and an immortalized ovarian epithelial cell line. Compared with the controls, HE4 overexpression significantly promoted cell apoptosis and adhesion. Overexpression of HE4 also led to significant inhibition of cell proliferation, migration and invasiveness in vitro, as well as xenograft tumour formation in vivo. This is the first report to demonstrate the functional importance of HE4 in multiple cellular processes and indicates that HE4 may play a protective role in the progression of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117965     DOI: 10.1177/147323001103900507

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.

Authors:  L-T Jia; Y-C Zhang; J Li; Y Tian; J-F Li
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

2.  Prognostic values of HE4 expression in patients with cancer: a meta-analysis.

Authors:  Cong Dai; Yi Zheng; Yuanjie Li; Tian Tian; Meng Wang; Peng Xu; Yujiao Deng; Qian Hao; Ying Wu; Zhen Zhai; Zhijun Dai; Jun Lyu
Journal:  Cancer Manag Res       Date:  2018-10-10       Impact factor: 3.989

3.  Interaction of HE4 and ANXA2 exists in various malignant cells-HE4-ANXA2-MMP2 protein complex promotes cell migration.

Authors:  Jing Wang; Lu Deng; Huiyu Zhuang; Juanjuan Liu; Dawo Liu; Xiao Li; Shan Jin; Liancheng Zhu; Huimin Wang; Bei Lin
Journal:  Cancer Cell Int       Date:  2019-06-13       Impact factor: 5.722

4.  HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases.

Authors:  Anita Chudecka-Głaz; Aneta Cymbaluk-Płoska; Janusz Menkiszak; Agnieszka Sompolska-Rzechuła; Elżbieta Byra; Izabella Rzepka-Górska
Journal:  J Ovarian Res       Date:  2014-02-14       Impact factor: 4.234

5.  Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

Authors:  Anita Monika Chudecka-Głaz; Aneta Alicja Cymbaluk-Płoska; Janusz Leszek Menkiszak; Agnieszka Monika Sompolska-Rzechuła; Aleksandra Izabela Tołoczko-Grabarek; Izabella Anna Rzepka-Górska
Journal:  J Ovarian Res       Date:  2014-06-10       Impact factor: 4.234

6.  Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.

Authors:  Sarikapan Wilailak; Karen K L Chan; Chi An Chen; Joo Hyun Nam; Kazunori Ochiai; Tar Choon Aw; Subathra Sabaratnam; Sudarshan Hebbar; Jaganathan Sickan; Beth A Schodin; Chuenkamon Charakorn; Walfrido W Sumpaico
Journal:  J Gynecol Oncol       Date:  2014-10-13       Impact factor: 4.401

7.  Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.

Authors:  Chen-Hui Luo; Min Zhao; Yu-Xi Tang; Shohreh Shahabi; Kai-Ning Fang; Yan Chen; Yan Tang; Xiao-Yan Chen; Jing Wang; Hong-Hao Zhou
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

Review 8.  Potential association between elevated serum human epididymis protein 4 and renal fibrosis: A systemic review and meta-analysis.

Authors:  Peipei Chen; Qiao Yang; Xuemei Li; Yan Qin
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.